Search results
FDA approves self-collection screening tests for HPV, allowing women to avoid pelvic exams for...
FierceBiotech· 1 day agoThe FDA has approved two diagnostic devices that allow women to collect vaginal samples themselves...
FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE...
FOX 5 San Diego· 1 hour agoAmgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRA™ (tarlatamab-dlle) for the treatment of adult patients with extensive-stage ...
FDA greenlights self-collection of vaginal samples for cervical cancer screening
KMBC-TV Kansas City· 5 hours agoTwo health care businesses – biotechnology company Roche and medical technology firm Becton, Dickson...
Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion
Zacks via Yahoo Finance· 11 hours agoBristol Myers Squibb (BMY) obtains FDA approval for the label expansion of CAR T cell therapy...
FDA said it never inspected dental lab that made controversial AGGA device
Medical Xpress· 13 hours agoThe FDA never inspected Johns Dental Laboratories during more than a decade in which it made the...
EPA, FDA, and USDA Issue Joint Regulatory Plan for Biotechnology
The National Law Review· 6 hours agoOn May 8, 2024, the U.S. Environmental Protection Agency (EPA), U.S. Food and Drug Administration (...
FDA approves Amgen's treatment for most deadly form of lung cancer
CNBC· 4 hours agoThe Food and Drug Administration on Thursday approved Amgen's therapy for patients with the most...
What to know about self-swabbing for HPV after FDA approves new kits
ABC News via Yahoo News· 6 hours agoFor the first time, women in the United States have the ability to self-collect a sample to screen...
FDA recalls Abbott’s HeartMate 3 ventricular assist device after 2 deaths
Medical Device Network via Yahoo Finance· 11 hours agoThe US Food and Drug Administration (FDA) has tagged a recall of Abbott’s HeartMate 3 left...
FDA Pushes Review Date For Ascendis Pharma's Hormone Disorder Candidate By Three Months
Benzinga via Yahoo Finance· 1 day agoTuesday, Ascendis Pharma A/S (NASDAQ:ASND) announced that the FDA extended the review date for...